These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10665121)

  • 21. [Prescription of Viagra: the Medical Products Agency does recommend].
    Byström J
    Lakartidningen; 2000 Feb; 97(8):870. PubMed ID: 10741034
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of sildenafil in treating erectile dysfunction in PTSD patients: a double-blind, placebo-controlled crossover study.
    Orr G; Weiser M; Polliack M; Raviv G; Tadmor D; Grunhaus L
    J Clin Psychopharmacol; 2006 Aug; 26(4):426-30. PubMed ID: 16855464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of phosphodiesterase 5 inhibitors.
    Carrier S
    Can J Urol; 2003 Feb; 10 Suppl 1():12-6. PubMed ID: 12625845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of sildenafil citrate (Viagra): a naturalistic cross-over study.
    Agelink MW; Schmitz T; Rembrink K; Beckerling D; Mück-Weymann M; Mercik D; Brockmeyer NH
    Eur J Med Res; 2001 Nov; 6(11):459-64. PubMed ID: 11726304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction.
    King R; Juenemann KP; Levinson IP; Stecher VJ; Creanga DL
    Int J Impot Res; 2007; 19(4):398-406. PubMed ID: 17361232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of oral sildenafil citrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study.
    Gómez F; Davila H; Costa A; Acuña A; Wadskier LA; Plua P;
    Int J Impot Res; 2002 Aug; 14 Suppl 2():S42-7. PubMed ID: 12161767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early sildenafil dose optimization and personalized instruction improves the frequency, flexibility, and success of sexual intercourse in men with erectile dysfunction.
    Steidle CP; McCullough AR; Kaminetsky JC; Crowley AR; Siegel RL; Deriesthal H; Tseng LJ
    Int J Impot Res; 2007; 19(2):154-60. PubMed ID: 16858367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sildenafil citrate (viagra) treatment in patients with diabetes mellitus].
    Kalinichenko SIu; Kozlov GI; Mel'nichenko GA; Dedov II
    Ter Arkh; 1999; 71(10):78-80. PubMed ID: 10612183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction in Brazilian and Mexican men.
    Glina S; Bertero E; Claro J; Damião R; Faria G; Fregonesi A; Jaspersen J; Mendoza A; Mattos D; Rocha LC; Sotomayor M; Telöken C; Ureta S; Zonana E; Ugarte F
    Int J Impot Res; 2002 Aug; 14 Suppl 2():S27-32. PubMed ID: 12161765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating erectile dysfunction: oral sildenafil versus intracavernosal injection of papaverine.
    Viswaroop B; B A; Gopalakrishnan G
    Natl Med J India; 2005; 18(6):299-301. PubMed ID: 16483029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sex--only for the rich and healthy? PDE5 inhibitors too expensive for low income men].
    Ströberg P; Hedelin H; Bergström A
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2865-7. PubMed ID: 17128920
    [No Abstract]   [Full Text] [Related]  

  • 33. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil.
    von Keitz A; Rajfer J; Segal S; Murphy A; Denne J; Costigan T; Lockhart D; Beasley CM; Emmick JT
    Eur Urol; 2004 Apr; 45(4):499-507; discussion 507-9. PubMed ID: 15041116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erectile dysfunction and sildenafil citrate.
    Gogtay NJ; Bichile SK; Pinto CJ; Kshirsagar NA
    J Assoc Physicians India; 2001 Sep; 49():871-2. PubMed ID: 11837751
    [No Abstract]   [Full Text] [Related]  

  • 35. A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (Viagra) for erectile dysfunction.
    McCullough AR; Carson CC; Hatzichristou D
    Urology; 2006 Sep; 68(3 Suppl):38-46. PubMed ID: 17011374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublingual sildenafil in the treatment of erectile dysfunction: faster onset of action with less dose.
    Deveci S; Peşkircioğlu L; Aygün C; Tekin MI; Dirim A; Ozkardeş H
    Int J Urol; 2004 Nov; 11(11):989-92. PubMed ID: 15509203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral sildenafil in the treatment of erectile dysfunction. 1998.
    Goldstein I; Lue TF; Padma-Nathan H; Rosen RC; Steers WD; Wicker PA;
    J Urol; 2002 Feb; 167(2 Pt 2):1197-203; discussion 1204. PubMed ID: 11905901
    [No Abstract]   [Full Text] [Related]  

  • 38. Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials.
    Blonde L
    Curr Med Res Opin; 2006 Nov; 22(11):2111-20. PubMed ID: 17076971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial.
    Pickering TG; Shepherd AM; Puddey I; Glasser DB; Orazem J; Sherman N; Mancia G
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1135-42. PubMed ID: 15607620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.
    Mathers MJ; Klotz T; Brandt AS; Roth S; Sommer F
    BJU Int; 2008 May; 101(9):1129-34. PubMed ID: 18190629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.